Cidara Therapeutics Inc. (CDTX)
NASDAQ: CDTX
· Real-Time Price · USD
65.38
1.83 (2.88%)
At close: Aug 15, 2025, 3:59 PM
66.25
1.33%
After-hours: Aug 15, 2025, 06:59 PM EDT
Cidara Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 510.57M | 168.15M | 189.82M | 127.39M | 164.37M | 29.02M | 35.78M | 48.67M | 50.43M | 47.98M | 32.73M | 53.08M | 24.64M | 36.49M | 62.27M | 36.6M | 48.28M | 42.86M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 95K | 96K | 96K | 1.24M | 104K | 987K | 1.05M | 1.05M | 1.06M | 1.06M | 1.07M | 1.29M | 1.01M | 1.02M | 533K | 1.17M | 1.96M | 1.96M |
Receivables | 1.86M | 1.69M | 1.69M | 1.7M | 2.35M | 7.28M | 16.25M | 2.85M | 5.48M | 25.83M | 5.83M | 5.04M | 4.83M | 8.78M | 5.36M | 3.87M | 3.16M | 11K |
Inventory | n/a | n/a | n/a | n/a | n/a | 7.27M | 6.1M | 2.47M | 1.95M | n/a | n/a | n/a | n/a | n/a | -2.59M | n/a | n/a | n/a |
Other Current Assets | 19.36M | 19M | 19.22M | 27.69M | 1.87M | 3.27M | 2.73M | 3.71M | 4.37M | 5.69M | 6.53M | 5.78M | 370K | 1.48M | 2.59M | 3.7M | 4.82M | 5.93M |
Total Current Assets | 531.79M | 188.85M | 210.74M | 156.77M | 168.59M | 46.83M | 60.85M | 57.7M | 62.24M | 79.49M | 45.09M | 63.9M | 36.55M | 52.01M | 71.7M | 47.28M | 61.08M | 51.3M |
Property-Plant & Equipment | 2.44M | 2.78M | 3.96M | 4.32M | 4.67M | 4.89M | 5.13M | 4.71M | 4.68M | 1.19M | 1.43M | 1.66M | 1.97M | 2.27M | 2.54M | 2.76M | 707K | 948K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.54M | 2.88M | 4.06M | 5.56M | 4.77M | 5.88M | 7.67M | 5.76M | 5.75M | 2.25M | 2.5M | 2.96M | 2.98M | 3.29M | 3.63M | 3.93M | 2.67M | 2.91M |
Total Assets | 534.33M | 191.73M | 214.8M | 162.33M | 173.36M | 52.72M | 68.53M | 63.47M | 67.99M | 81.74M | 47.59M | 66.86M | 39.52M | 55.3M | 75.33M | 51.21M | 63.74M | 54.21M |
Account Payables | 2.21M | 4.9M | 3.61M | 2.97M | 2.29M | 5.05M | 3.77M | 3.66M | 1.9M | 3.98M | 1.45M | 4.24M | 3.09M | 2.86M | 1.3M | 3.24M | 2.59M | 3.21M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 24.32M | 25.09M | 14.68M | 14.97M | 15.76M | 14.61M | 15.25M | 14.73M | 14.26M | 13.92M | 13.03M | 14.46M | 15.41M |
Short-Term Debt | 1.5M | n/a | n/a | n/a | n/a | 1.46M | 1.3M | 1.05M | n/a | n/a | 1.32M | 1.28M | 1.6M | 2.67M | 3.74M | 4.73M | 5.29M | 6.63M |
Other Current Liabilities | 25.99M | 1.92M | n/a | 39.79M | 29.61M | 27.39M | 30.92M | 10.72M | 10.02M | 5.84M | 6.46M | 6.88M | 7.33M | 8.04M | 9.05M | 7.5M | 7.62M | 8.33M |
Total Current Liabilities | 32.32M | 48.81M | 49.55M | 44.34M | 39.64M | 65.42M | 67.42M | 35.62M | 31.42M | 35.66M | 29.97M | 33.05M | 31.45M | 32.1M | 34.02M | 33.49M | 33.89M | 39.97M |
Long-Term Debt | 836K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 1.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 836K | 1.24M | 1.93M | 2.36M | 2.78M | 5.07M | 9.32M | 19.81M | 21.15M | 19.24M | 20.52M | 24.74M | 16.03M | 18.23M | 19.73M | 18.87M | 14.07M | 12.35M |
Total Liabilities | 33.15M | 50.05M | 51.49M | 46.7M | 42.42M | 70.5M | 76.74M | 55.43M | 52.57M | 54.9M | 50.5M | 57.79M | 47.48M | 50.34M | 53.75M | 52.36M | 47.95M | 52.32M |
Total Debt | 2.33M | 2.67M | 3.58M | 3.94M | 4.3M | 4.65M | 4.88M | 4.36M | 4.54M | 1M | 1.32M | 1.62M | 2.28M | 3.67M | 5.06M | 6.35M | 5.29M | 6.63M |
Common Stock | 2K | 1K | 1K | 1K | 1K | 1K | 9K | 9K | 9K | 9K | 7K | 7K | 7K | 7K | 7K | 5K | 5K | 5K |
Retained Earnings | -660.46M | -634.74M | -611.26M | -558.95M | -542.97M | -451.76M | -441.43M | -424.29M | -416.11M | -403.76M | -406.97M | -393.59M | -408.57M | -395.45M | -377.17M | -360.36M | -342.28M | -352.99M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | -0.00 | -0.00 | -0.00 | n/a | n/a |
Shareholders Equity | 501.17M | 141.68M | 163.31M | 115.63M | 130.94M | -17.78M | -8.21M | 8.04M | 15.41M | 26.84M | -2.9M | 9.07M | -7.96M | 4.96M | 21.57M | -1.16M | 15.79M | 1.89M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |